Drug Shortage Report for FUROSEMIDE INJECTION USP

Last updated on 2024-02-14 History
Report ID 210680
Drug Identification Number 02384094
Brand name FUROSEMIDE INJECTION USP
Common or Proper name FUROSEMIDE INJECTION USP
Company Name HIKMA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) FUROSEMIDE
Strength(s) 20MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR
Packaging size 2mL
ATC code C03CA
ATC description HIGH-CEILING DIURETICS
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2023-11-17
Actual start date
Estimated end date 2024-03-01
Actual end date 2024-02-13
Shortage status Resolved
Updated date 2024-02-14
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 5995 AVEBURY ROAD, SUITE 804
MISSISSAUGA, ONTARIO
CANADA L5R 3P9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2024-02-14 French Compare
v4 2024-02-14 English Compare
v3 2023-11-18 English Compare
v2 2023-11-17 French Compare
v1 2023-11-17 English Compare

Showing 1 to 5 of 5